CPhI Russia Returns to Moscow

Article

The conference will gather more than 3000 attendees from 64 countries.

CPhI Russia returns to Moscow from March 28–30, 2017. The event will gather more than 3000 attendees from 64 countries, and 199 exhibitors to network and do business with pharma ingredients, manufacturers, packaging experts, and machining specialists in the region. Attendees will gain in-depth insights from the International Forum, a dedicated matchmaking program, speaker sessions, and other networking opportunities. The program includes detailed analysis on compulsory licensing, drugs labeling, and modern assortment solutions and global trends in the pharmaceutical packaging industry. CPhI Russia offers a matchmaking service that allows companies to meet with relevant partners during the show–it also enables sellers to become buyers as they see new potential suppliers.

According to CPhI, the partnerships and deals struck at CPhI Russia have helped establish Russia at the forefront of pharmerging markets and it is expected to reach a value of $31.2 billion by 2019. This, coupled with a government commitment to invest nearly $5 billion in funding to bring existing manufacturing sites to GMP standards, is driving increased interest in the event. Under the new plan, foreign investment is also encouraged through a fast-track approval process and tax incentives.

“We are seeing a steady growth in three main areas driven by a gentrifying healthcare sector, a rising local population, and government support for domestic manufacturing. Currency variation aside, the pharma market is growing at just under 10% year-on-year and distributers, APIs manufacturers, and machinery providers are seeing high demand across Russia and CIS countries. Traditionally, Russia has been a hard market to enter and that is why CPhI Russia has become so intertwined with the market’s growth,” said Orhan Caglayan, brand director at CPhI Russia in a statement.

Source: CPhI Russia

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content